Teladoc Health, Inc. (NYSE:TDOC) Receives Consensus Rating of “Hold” from Analysts

Shares of Teladoc Health, Inc. (NYSE:TDOC) have earned an average recommendation of “Hold” from the twenty-one research firms that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, fourteen have assigned a hold recommendation and six have assigned a buy recommendation to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $7.6389.

Several research analysts have recently issued reports on TDOC shares. Deutsche Bank Aktiengesellschaft raised Teladoc Health from a “hold” rating to a “buy” rating and set a $11.00 price target for the company in a research note on Tuesday, March 10th. TD Cowen reduced their price objective on shares of Teladoc Health from $8.00 to $6.00 and set a “hold” rating for the company in a report on Thursday, February 26th. Bank of America upgraded shares of Teladoc Health from a “neutral” rating to a “buy” rating and set a $7.00 target price for the company in a research report on Thursday, February 26th. Canaccord Genuity Group lowered their target price on shares of Teladoc Health from $12.00 to $10.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Finally, Piper Sandler restated an “overweight” rating and set a $9.00 price target (down from $12.00) on shares of Teladoc Health in a research report on Thursday, February 26th.

Insider Activity

In related news, CEO Charles Divita III sold 27,731 shares of the firm’s stock in a transaction that occurred on Wednesday, March 11th. The shares were sold at an average price of $5.49, for a total transaction of $152,243.19. Following the transaction, the chief executive officer owned 364,784 shares in the company, valued at $2,002,664.16. This trade represents a 7.06% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.58% of the stock is owned by company insiders.

Hedge Funds Weigh In On Teladoc Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. PNC Financial Services Group Inc. increased its position in shares of Teladoc Health by 177.7% during the 4th quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock valued at $31,000 after purchasing an additional 2,810 shares during the period. IFP Advisors Inc lifted its holdings in shares of Teladoc Health by 412.1% in the third quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock valued at $31,000 after buying an additional 3,210 shares during the period. Aster Capital Management DIFC Ltd boosted its stake in Teladoc Health by 101.1% during the third quarter. Aster Capital Management DIFC Ltd now owns 4,823 shares of the health services provider’s stock valued at $37,000 after buying an additional 2,425 shares in the last quarter. International Assets Investment Management LLC bought a new position in Teladoc Health during the fourth quarter valued at about $45,000. Finally, Bayforest Capital Ltd acquired a new position in Teladoc Health during the third quarter worth about $58,000. 76.82% of the stock is owned by institutional investors.

Teladoc Health Stock Performance

TDOC opened at $5.15 on Friday. The company has a current ratio of 2.77, a quick ratio of 2.67 and a debt-to-equity ratio of 0.72. The business’s 50 day moving average is $5.28 and its 200-day moving average is $6.89. The stock has a market cap of $917.87 million, a PE ratio of -4.51 and a beta of 2.13. Teladoc Health has a twelve month low of $4.40 and a twelve month high of $9.77.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, February 25th. The health services provider reported ($0.14) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.19) by $0.05. The business had revenue of $642.27 million during the quarter, compared to analyst estimates of $635.33 million. Teladoc Health had a negative return on equity of 9.13% and a negative net margin of 7.92%.The business’s revenue for the quarter was up .3% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.28) EPS. Teladoc Health has set its Q1 2026 guidance at -0.450–0.350 EPS and its FY 2026 guidance at -1.100–0.700 EPS. On average, analysts predict that Teladoc Health will post -1.16 earnings per share for the current year.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.